19338005: 2 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module

3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
2	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
2	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely codeine phosphate 30 milligram and paracetamol 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 12.8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 325 milligram and methocarbamol 400 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 60 milligram and paracetamol 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 81 milligram and pravastatin 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely candesartan cilexetil 32 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 81 milligram and pravastatin 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely acrivastine 8 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dexbrompheniramine maleate 6 milligram and pseudoephedrine sulfate 120 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 81 milligram and pravastatin 80 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 4.5 milligram and oxycodone terephthalate 380 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 325 milligram and pravastatin 80 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 325 milligram and pravastatin 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atenolol 100 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine 5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlordiazepoxide hydrochloride 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac sodium 75 milligram and misoprostol 200 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atenolol 50 milligram and chlortalidone 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 5 milligram and valsartan 320 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine 10 milligram and telmisartan 80 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atenolol 50 milligram and chlortalidone 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely desogestrel 150 microgram and ethinylestradiol 20 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 5 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 10 milligram and valsartan 160 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely azatadine maleate 1 milligram and pseudoephedrine sulfate 120 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely ampicillin 250 milligram and flucloxacillin 250 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 10 milligram and valsartan 320 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin 800 milligram and clavulanate potassium 125 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlorphenamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aluminium hydroxide 600 milligram and magnesium hydroxide 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 200 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benazepril hydrochloride 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benazepril hydrochloride 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely choline bitartrate 25 milligram and dexpanthenol 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amitriptyline 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely caffeine 25 milligram and paracetamol 450 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 630 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac sodium 50 milligram and misoprostol 200 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benzocaine 10 milligram and dequalinium chloride 250 microgram/1 each conventional release oromucosal lozenge	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amlodipine besilate 2.5 milligram and atorvastatin 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amitriptyline 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 2.5 milligram and potassium chloride 573 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amiloride hydrochloride 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 20 milligram and ibuprofen 300 milligram/1 each prolonged-release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amobarbital sodium 100 milligram and secobarbital sodium 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely butalbital 50 milligram and paracetamol 650 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier

Start Page 2 of 35 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442102012	2 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442103019	2	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module